COVID-19 and anosmia: A review based on up-to-date knowledge

Xiangming Meng, Yanzhong Deng, Zhiyong Dai, Zhisheng Meng, Xiangming Meng, Yanzhong Deng, Zhiyong Dai, Zhisheng Meng

Abstract

The pandemic of Coronavirus Disease 2019 (COVID-19) has caused a vast disaster throughout the world. There is increasing evidence that olfactory dysfunction can present in COVID-19 patients. Anosmia can occur alone or can be accompanied by other symptoms of COVID-19, such as a dry cough. However, the pathogenic mechanism of olfactory dysfunction and its clinical characteristics in patients with COVID-19 remains unclear. Multiple cross-sectional studies have demonstrated that the incidence rate of olfactory dysfunction in COVID-19 patients varies from 33.9-68% with female dominance. Anosmia and dysgeusia are often comorbid in COVID-19 patients. Otolaryngologists should be mindful of the symptom of anosmia in outpatients so as not to delay the diagnosis of COVID-19. In this paper, we have reviewed the relevant knowledge based on up-to-date literature.

Keywords: Anosmia; COVID-19; Coronavirus; Olfactory dysfunction; Otolaryngology; SARS-CoV-2; Smell.

Conflict of interest statement

Declaration of competing interest The authors declare that they have no competing interests.

Copyright © 2020 Elsevier Inc. All rights reserved.

References

    1. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199–1207. doi: 10.1056/NEJMoa2001316.
    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. doi: 10.1056/NEJMoa2002032.
    1. World Health Organization Coronavirus disease 2019 (COVID-19) situation report-104.
    1. World Health Organization WHO Director-General's remarks at the media briefing on2019-nCoV on 11 February 2020.
    1. Mao L., Jin H., Wang M., Hu Y., Chen S., He Q. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.1127. [Apr 10. [Epub ahead of print]]
    1. Lovato A., de Filippis C., Marioni G. Upper airway symptoms in coronavirus disease 2019 (COVID-19) Am J Otolaryngol. 2020:102474. doi: 10.1016/j.amjoto.2020.102474. [Apr 4. [Epub ahead of print]]
    1. Lovato A., de Filippis C. Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms. Ear Nose Throat J. 2020 doi: 10.1177/0145561320920762. [145561320920762, Apr 13. [Epub ahead of print]]
    1. Marchese-Ragona R., Ottaviano G., Nicolai P., Vianello A., Carecchio M. Sudden hyposmia as a prevalent symptom of COVID-19 infection. medRxiv. 2020 doi: 10.1101/2020.04.06.20045393. [2004.2006.20045393, Apr 7. [Epub ahead of print]]
    1. Wu Y., Xu X., Chen Z., Duan J., Hashimoto K., Yang L. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. Mar 30, 2020 doi: 10.1016/j.bbi.2020.03.031. [pii: S0889-1591(20)30357-3, [Epub ahead of print]]
    1. Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Nerosci. 2020;11:995–998. doi: 10.1021/acschemneuro.0c00122.
    1. Yeo C., Kaushal S., Yeo D. Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol. 2020;5:335–337. doi: 10.1016/S2468-1253(20)30048-0.
    1. Koyuncu O.O., Hogue I.B., Enquist L.W. Virus infections in the nervous system. Cell Host Microbe. 2013;13:379–393. doi: 10.1016/j.chom.2013.03.010.
    1. Baig A.M. Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS Neurosci Ther. 2020;26:499–501. doi: 10.1111/cns.13372.
    1. Rockx B., Kuiken T., Herfst S., Bestebroer T., Lamers M.M., Oude Munnink B.B. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science. 2020;368:1012–1015. doi: 10.1126/science.abb7314.
    1. Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382:1177–1179. doi: 10.1056/NEJMc2001737.
    1. Sungnak W., Huang N., Bécavin C., Berg M., Queen R., Litvinukova M. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26:681–687. doi: 10.1038/s41591-020-0868-6.
    1. Gengler I., Wang J.C., Speth M.M., Sedaghat A.R. Laryngoscope investigative otolaryngology. April 10, 2020. Sinonasal pathophysiology of SARS-CoV-2 and COVID-19: a systematic review of the current evidence.
    1. Colavita F., Lapa D., Carletti F., Lalle E., Bordi L., Marsella P. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med. 2020 doi: 10.7326/M20-1176. [M20-1176, Apr 17. [Epub ahead of print]]
    1. Hummel T., Whitcroft K.L., Andrews P., Altundag A., Cinghi C., Costanzo R.M. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54:1–30.
    1. Soler Z.M., Patel Z.M., Turner J.H., Holbrook E.H. A primer on viral-associated olfactory loss in the era of COVID-19. Int Forum Allergy Rhinol. 2020 doi: 10.1002/alr.22578. [Apr 9. [Epub ahead of print]]
    1. Akerlund A., Bende M., Murphy C. Olfactory threshold and nasal mucosal changes in experimentally induced common cold. Acta Otolaryngol. 1995;115:88–92. doi: 10.3109/00016489509133353.
    1. Hwang C.S. Olfactory neuropathy in severe acute respiratory syndrome: report of a case. Acta Neurol Taiwan. 2006;15:26–28.
    1. Lechien J.R., Chiesa-Estomba C.M., De Siati D.R., Horoi M., Le Bon S.D., Rodriguez A. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 doi: 10.1007/s00405-020-05965-1. [Apr 6. [Epub ahead of print]]
    1. Heidari F., Karimi E., Firouzifar M., Khamushian P., Ansari R., Mohammadi Ardehali M. Anosmia as a prominent symptom of COVID-19 infection. Rhinology. 2020;58:302–303. doi: 10.4193/Rhin20.140.
    1. Gane S.B., Kelly C., Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology. 2020;58:299–301. doi: 10.4193/Rhin20.114.
    1. Eliezer M., Hautefort C., Hamel A.L., Verillaud B., Herman P., Houdart E. Sudden and complete olfactory loss function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. 2020 doi: 10.1001/jamaoto.2020.0832. [Apr 8. [Epub ahead of print]]
    1. Klopfenstein T., Kadiane-Oussou N.J., Toko L., Royer P.Y., Lepiller Q., Gendrin V. Features of anosmia in COVID-19. Med Mal Infect. 2020 doi: 10.1016/j.medmal.2020.04.006. [pii: S0399-077X(20)30110-4, Apr 17. [Epub ahead of print]]
    1. Luers J.C., Rokohl A.C., Loreck N., Wawer Matos P.A., Augustin M., Dewald F. Olfactory and gustatory dysfunction in coronavirus disease 19 (COVID-19) Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa525. [ciaa525, May 1. [Epub ahead of print]]
    1. Giacomelli A., Pezzati L., Conti F., Bernacchia D., Siano M., Oreni L. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa330. [ciaa330, Mar 26. [Epub ahead of print]]
    1. Bagheri S.H.R., Asghari A.M., Farhadi M., Shamshiri A.R., Kabir A., Kamrava S.K. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak. medRxiv. 2020 doi: 10.1101/2020.03.23.20041889. [2020.2003.2023.20041889, March 27]
    1. Menni C., Valdes A., Freydin M.B., Ganesh S., El-Sayed Moustafa J., Visconti A. Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection. medRxiv. 2020 doi: 10.1101/2020.04.05.20048421. [2020.2004.2005.20048421. April 07]
    1. Yan C.H., Faraji F., Prajapati D.P., Boone C.E., DeConde A.S. Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020 [Epub ahead of print]
    1. Spinato G., Fabbris C., Polesel J., Cazzador D., Borsetto D., Hopkins C. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. Jama. 2020;323:2089–2090. doi: 10.1001/jama.2020.6771.
    1. Jafek B.W., Murrow B., Michaels R., Restrepo D., Linschoten M. Biopsies of human olfactory epithelium. Chem Senses. 2002;27:623–628. doi: 10.1093/chemse/27.7.623.
    1. Moein S.T., Hashemian S.M.R., Mansourafshar B., Khorram-Tousi A., Tabarsi P., Doty R.L. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020 doi: 10.1002/alr.22587. [Apr 17. [Epub ahead of print]]
    1. Beltrán-Corbellini Á., Chico-García J.L., Martínez-Poles J., Rodríguez-Jorge F., Natera-Villalba E., Gómez-Corral J. Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study. Eur J Neurol. 2020 doi: 10.1111/ene.14273. [Apr 22. [Epub ahead of print]]
    1. Ottaviano G., Carecchio M., Scarpa B., Marchese-Ragona R. Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss. Rhinology. 2020 doi: 10.4193/Rhin20.136. [Apr 27. [Epub ahead of print]]
    1. Vaira L.A., Salzano G., Petrocelli M., Deiana G., Salzano F.A., De Riu G. Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine. Head Neck. 2020 doi: 10.1002/hed.26228. [May 1. [Epub ahead of print]]
    1. Shweta F., Murugadoss K., Awasthi S., Venkatakrishnan A., Puranik A., Kang M. Augmented curation of unstructured clinical notes from a massive EHR system reveals specific phenotypic signature of impending COVID-19 diagnosis. arXiv preprint. 2020 [arXiv:200409338. Apr 17]
    1. Williams F.M., Freydin M., Mangino M., Couvreur S., Visconti A., Bowyer R.C. Self-reported symptoms of covid-19 including symptoms most predictive of SARS-CoV-2 infection, are heritable. medRxiv. 2020 doi: 10.1101/2020.04.22.20072124. [2020.2004.2022.20072124, April 27]
    1. Braun T., Harréus U. Medical nowcasting using Google trends: application in otolaryngology. Eur Arch Otorhinolaryngol. 2013;270:2157–2160. doi: 10.1007/s00405-013-2532-y.
    1. Walker A., Hopkins C., Surda P. The use of google trends to investigate the loss of smell related searches during COVID-19 outbreak. Int Forum Allergy Rhinol. 2020 [Epub ahead of print]
    1. Yao H., Lu X., Chen Q., Xu K., Chen Y., Cheng L. Patient-derived mutations impact pathogenicity of SARS-CoV-2. medRxiv. 2020 doi: 10.1101/2020.04.14.20060160. [2020.2004.2014.20060160, April 27]
    1. Forster P., Forster L., Renfrew C., Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci U S A. 2020;117:9241–9243. doi: 10.1073/pnas.2004999117.
    1. Hopkins C., Kumar N. Loss of sense of smell as marker of COVID-19 infection.
    1. American Academy of Otolaryngology- Head and Neck Surgery Anosmia: new! COVID-19 anosmia reporting tool open to all clinicians.
    1. Centers for Disease Control and Prevention Symptoms of coronavirus.
    1. Pleasure S.J., Green A.J., Josephson S.A. The Spectrum of neurologic disease in the severe acute respiratory syndrome coronavirus 2 pandemic infection: neurologists move to the frontlines. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.1065. [Apr 10. [Epub ahead of print]]
    1. Ruthberg J.S., Quereshy H.A., Jella T., Kocharyan A., D’Anza B., Maronian N. Geospatial analysis of COVID-19 and otolaryngologists above age 60. Am J Otolaryngol. 2020:102514. doi: 10.1016/j.amjoto.2020.102514. [Apr 30.[Epub ahead of print]]
    1. Zhao C., Viana A., Jr., Wang Y., Wei H.Q., Yan A.H., Capasso R. Otolaryngology during COVID-19: preventive care and precautionary measures. Am J Otolaryngol. 2020:102508. [Epub ahead of print]
    1. Liu Y., Ning Z., Chen Y., Guo M., Liu Y., Gali N.K. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature. 2020 doi: 10.1038/s41586-020-2271-3. [Apr 27. [Epub ahead of print]]
    1. Meng X., Dai Z., Hang C., Wang Y. Smartphone-enabled wireless otoscope-assisted online telemedicine during the COVID-19 outbreak. Am J Otolaryngol. 2020:102476. doi: 10.1016/j.amjoto.2020.102476. [Apr 4. [Epub ahead of print]]
    1. Vaira L.A., Salzano G., Deiana G., De Riu G. Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. 2020 doi: 10.1002/lary.28692. [Apr 1. [Epub ahead of print]]
    1. Villalba N.L., Maouche Y., Ortiz M.B.A., Sosa Z.C., Chahbazian J.B., Syrovatkova A. Anosmia and dysgeusia in the absence of other respiratory diseases: should COVID-19 infection be considered? Eur J Case Rep Intern Med. 2020;7:1641. doi: 10.12890/2020_001641.
    1. Hjelmesæth J; Skaare D, Loss of smell or taste as the only symptom of COVID-19. Tidsskr Nor Laegeforen 2020;140:7.doi:10.4045/tidsskr.20.0287.
    1. Yan C.H., Faraji F., Prajapati D.P., Ostrander B.T., DeConde A.S. Self-reported olfactory loss associates with outpatient clinical course in Covid-19. Int Forum Allergy Rhinol. 2020 doi: 10.1002/alr.22592. [Apr 24. [Epub ahead of print]]
    1. Kaye R., Chang C.W.D., Kazahaya K., Brereton J., Denneny J.C., 3rd COVID-19 anosmia reporting tool: initial findings. Otolaryngol Head Neck Surg. 2020 [194599820922992, Epub ahead of print]
    1. Gilani S., Roditi R., Naraghi M. COVID-19 and anosmia in Tehran, Iran. Med Hypotheses. 2020;141:109757. doi: 10.1016/j.mehy.2020.109757. [Apr 23. [Epub ahead of print]]

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever